Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.

Duke criteria Streptococci bloodstream infection infective endocarditis sepsis

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 16 03 2024
revised: 22 05 2024
accepted: 04 06 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 6 6 2024
Statut: aheadofprint

Résumé

Streptococci are a common cause of infective endocarditis (IE). We aimed to evaluate the performance of the HANDOC score to identify patients at high-risk for IE and the Duke clinical criteria of the European Society of Cardiology (ESC; 2015 and 2023 versions) and the 2023 version from the International Society of Cardiovascular Infectious Diseases (ISCVID) in diagnosing IE among patients with streptococcal bacteremia. This retrospective study included adult patients with streptococcal bacteremia hospitalized at Lausanne University Hospital. Episodes were classified as IE by the Endocarditis Team. A HANDOC score >2 classified patients as high-risk for IE. Among 851 episodes with streptococcal bacteremia, IE was diagnosed in 171 episodes (20%). Among 607 episodes with non-beta-hemolytic streptococci, 213 (35%) had HANDOC scores >2 points; 132 (22%) had IE. The sensitivity of the HANDOC score to identify episodes at high-risk for IE was 95% (90-98%), the specificity 82% (78-85%), and the NPV 98% (96-99%). 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria classified 114 (13%), 145 (17%), and 126 (15%) episodes as definite IE, respectively. Sensitivity for the 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria was calculated at 65% (57-72%), 81% (74-86%), and 73% (65-79%), respectively, with specificity at 100% (98-100%), 99% (98-100%), and 99% (98-100%), respectively. The HANDOC score showed an excellent NPV to identify episodes at high-risk for IE. Among the different versions of the Duke criteria, the 2023 Duke-ISCVID version fared better for the diagnosis of IE among streptococcal bacteremia.

Sections du résumé

BACKGROUND BACKGROUND
Streptococci are a common cause of infective endocarditis (IE). We aimed to evaluate the performance of the HANDOC score to identify patients at high-risk for IE and the Duke clinical criteria of the European Society of Cardiology (ESC; 2015 and 2023 versions) and the 2023 version from the International Society of Cardiovascular Infectious Diseases (ISCVID) in diagnosing IE among patients with streptococcal bacteremia.
METHODS METHODS
This retrospective study included adult patients with streptococcal bacteremia hospitalized at Lausanne University Hospital. Episodes were classified as IE by the Endocarditis Team. A HANDOC score >2 classified patients as high-risk for IE.
RESULTS RESULTS
Among 851 episodes with streptococcal bacteremia, IE was diagnosed in 171 episodes (20%). Among 607 episodes with non-beta-hemolytic streptococci, 213 (35%) had HANDOC scores >2 points; 132 (22%) had IE. The sensitivity of the HANDOC score to identify episodes at high-risk for IE was 95% (90-98%), the specificity 82% (78-85%), and the NPV 98% (96-99%). 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria classified 114 (13%), 145 (17%), and 126 (15%) episodes as definite IE, respectively. Sensitivity for the 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria was calculated at 65% (57-72%), 81% (74-86%), and 73% (65-79%), respectively, with specificity at 100% (98-100%), 99% (98-100%), and 99% (98-100%), respectively.
CONCLUSIONS CONCLUSIONS
The HANDOC score showed an excellent NPV to identify episodes at high-risk for IE. Among the different versions of the Duke criteria, the 2023 Duke-ISCVID version fared better for the diagnosis of IE among streptococcal bacteremia.

Identifiants

pubmed: 38842414
pii: 7688884
doi: 10.1093/cid/ciae315
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Nicolas Fourre (N)

Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.

Virgile Zimmermann (V)

Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.

Laurence Senn (L)

Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.
Infection Prevention and Control Unit, Lausanne University Hospital, Lausanne, Switzerland.

Pierre Monney (P)

Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Georgios Tzimas (G)

Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Giorgia Caruana (G)

Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.

Piergiorgio Tozzi (P)

Department of Cardiac Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Matthias Kirsch (M)

Department of Cardiac Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Benoit Guery (B)

Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.

Matthaios Papadimitriou-Olivgeris (M)

Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.
Infection Prevention and Control Unit, Lausanne University Hospital, Lausanne, Switzerland.
Infectious Diseases Service, Cantonal Hospital of Sion and Institut Central des Hôpitaux (ICH), Sion, Switzerland.

Classifications MeSH